Experience of a Portuguese Center: Effectiveness of Direct-Acting Antiviral Therapy for Hepatitis C

V Vacina contra salmonelose, radiofármaco para tratamen- to de câncer, chocolate de cupuaçu, mini-estação para tratamento de esgoto, herbicida menos poluente, plásticos

Abstract: Drawing upon the articulation of two recently published works in Brazil: A estetização do mundo (Le esthétisation du Monde) by Gilles Lipovetsky and Jean Serroy (2015)

The aim of this study was to review the literature, seeking to examine the prevalence of human immunodeficiency virus/hepatitis C virus co-infection reported in studies conducted

The phase II study included 25 naive non-cirrhotic patients (15 with HCV genotype 2 and 10 with genotype 3 infection) treated with SOF plus PegIFN/RBV for 12 weeks, reaching an

The aim of this study was to determine risk factors for adverse events (AE)-related treatment discontinuation and severe anemia among patients with chronic hepatitis C virus

– Resultados do modelo formulado considerando o efeito escala no custo de manutenção das opções para o condomínio décimo quinto ano de operação.. – Resultados do modelo

Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin

Evolução: apresentou hipertensão arterial leve (150/100 mmHg) nos dois primeiros dias de internação, normalizando-se posteriormente.. Alta hospitalar no 109 dia de